Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 4Depression 4Head and Neck Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Fatigue 2Anxiety Disorders 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Sleep Wake Disorders 1Recurrence 1Radiation Fibrosis Syndrome 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Acceptance of Health Care 1Pain 1Neoplasm Metastasis 1Myasthenia Gravis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Calculi 1Inflammatory Breast Neoplasms 1Immune Checkpoint Inhibitor-Induced Dermatitis 1Health Education 1Constriction, Pathologic 1

Interventions

pembrolizumab 12Cisplatin 11Specimen Handling 9Bevacizumab 7Brachytherapy 6Platinum 5Paclitaxel 5Nivolumab 5Magnetic Resonance Spectroscopy 5Human Papillomavirus DNA Tests 5Colposcopy 5Carboplatin 5atezolizumab 4Gemcitabine 4Fulvestrant 4Surveys and Questionnaires 3Radiotherapy 3Radiation Dose Hypofractionation 3Radiation 3Drug Therapy 3Blood Specimen Collection 31,2-diaminocyclohexaneplatinum II citrate 3tisotumab vedotin 2palbociclib 2lenvatinib 2Topotecan 2Restraint, Physical 2Radiotherapy, Intensity-Modulated 2Pemetrexed 2Magnetic Resonance Imaging 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Therapeutics × 90 days × Clear all
NCT07542717 2026-04-21

ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Not yet recruiting
41 enrolled
Gynecologic

Uterine Cervical Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡